REFERENCES

1. Muggia FM. Doxil in breast cancer. J Clin Oncol 1998;16:811-2.

2. Porche DJ. Liposomal doxorubicin (doxil). J Assoc Nurses AIDS Care 1996;7:55-9.

3. Tagami T, Ozeki T. Recent trends in clinical trials related to carrier-based drugs. J Pharm Sci 2017;106:2219-26.

4. Cagel M, Tesan FC, Bernabeu E, Salgueiro MJ, Zubillaga MB, Moretton MA, Chiappetta DA. Polymeric mixed micelles as nanomedicines: achievements and perspectives. Eur J Pharm Biopharm 2017;113:211-28.

5. Lammers T, Kiessling F, Hennink WE, Storm G. Drug targeting to tumors: principles, pitfalls and (pre-) clinical progress. J Control Release 2012;161:175-87.

6. Hermanson GT. Bioconjugate Techniques, 3rd Edition. Academic Press; 2013.

7. Duncan R. Polymer conjugates as anticancer nanomedicines. Nat Rev Cancer 2006;6:688-701.